glioma patients : anaplasic glioma (grade III) and GBM (grade IV)
Showing 1 - 25 of >10,000
High Grade Glioma, Glioblastoma Trial in Cleveland (Standard Surgical Treatment, Intraoperative Electrocorticography)
Not yet recruiting
- High Grade Glioma
- Glioblastoma
- Standard Surgical Treatment
- Intraoperative Electrocorticography
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Sep 30, 2022
GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))
Completed
- GBM
- +3 more
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022
Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
- +3 more
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 21, 2022
Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)
Not yet recruiting
- Grade III or Grade IV Glioma
- PET imaging with 18F fluciclovine
- (no location specified)
Jul 27, 2022
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Supramaximal Resection Versus Maximal Resection for High-Grade
Recruiting
- Glioblastoma
- +11 more
- Supramaximal resection
- Maximal safe resection
-
San Francisco, California
- +7 more
Nov 1, 2023
Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)
Not yet recruiting
- Malignant Glioma
- Glioblastoma
- hEGFRvIII-CD3 (BRiTE)
- Activated Cell Therapy
-
Durham, North CarolinaDuke University Medical Center
Jun 24, 2022
Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial
Recruiting
- Glioma, Malignant
- +6 more
- Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 13, 2023
Glioblastoma Multiforme Trial in Los Angeles, Cleveland (Perillyl alcohol)
Recruiting
- Glioblastoma Multiforme
- Perillyl alcohol
-
Los Angeles, California
- +1 more
Sep 23, 2022
Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)
Recruiting
- Glioma
- +7 more
- Laparoscopically harvested omental tissue autograft
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 31, 2023
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Glioblastoma, Glioma, Glioblastoma Multiforme Trial in Phoenix (AZD1390)
Recruiting
- Glioblastoma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 10, 2022
Malignant Glioma Trial in United States (PVSRIPO)
Active, not recruiting
- Malignant Glioma
- PVSRIPO
-
San Francisco, California
- +5 more
Jun 28, 2022
High Grade Glioma Trial in Basel (endurance training, social support and counseling, resistance training)
Completed
- High Grade Glioma
- endurance training
- +2 more
-
Basel, Switzerland
- +1 more
May 17, 2022
Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria
Suspended
- Glioblastoma
- Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and
Recruiting
- Malignant Glioma of Brain
- +8 more
- Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
-
Detroit, MichiganHenry Ford Health System
Jan 9, 2023
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Withdrawn
- Recurrent Anaplastic Astrocytoma
- +7 more
- Neural Stem Cells-expressing CRAd-S-pk7
- Resection
- (no location specified)
Nov 22, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Glioblastoma, Recurrent Adult Brain Tumor, Malignant Glioma Trial in Richmond (sorafenib tosylate, valproic acid, sildenafil
Active, not recruiting
- Glioblastoma
- +3 more
- sorafenib tosylate
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Mar 21, 2022
Vascular Habitats Within Astrocytoma Grade 4 at Molecular,
Recruiting
- Astrocytoma, Grade IV
- +7 more
-
Valencia, SpainBiomedical Data Science Lab. Universitat Politècnica de València
May 11, 2022
ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
Recruiting
- Glioma, Malignant
- Glioblastoma
- Magnetic Resonance guided Focused ultrasound (MRgFUS)
-
Milano, Italy
- +1 more
Dec 15, 2021